These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32046073)
41. Assessment of the progression of Parkinson's disease: a metabolic network approach. Eckert T; Tang C; Eidelberg D Lancet Neurol; 2007 Oct; 6(10):926-32. PubMed ID: 17884682 [TBL] [Abstract][Full Text] [Related]
42. Morphological changes in Parkinson's disease based on magnetic resonance imaging: A mini-review of subcortical structures segmentation and shape analysis. Deng JH; Zhang HW; Liu XL; Deng HZ; Lin F World J Psychiatry; 2022 Dec; 12(12):1356-1366. PubMed ID: 36579355 [TBL] [Abstract][Full Text] [Related]
43. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006 [TBL] [Abstract][Full Text] [Related]
44. Integrating fNIRS and machine learning: shedding light on Parkinson's disease detection. Guevara E; Solana-Lavalle G; Rosas-Romero R EXCLI J; 2024; 23():763-771. PubMed ID: 38983780 [TBL] [Abstract][Full Text] [Related]
45. Texture, Morphology, and Statistical Analysis to Differentiate Primary Brain Tumors on Two-Dimensional Magnetic Resonance Imaging Scans Using Artificial Intelligence Techniques. Bhattacharjee S; Prakash D; Kim CH; Kim HC; Choi HK Healthc Inform Res; 2022 Jan; 28(1):46-57. PubMed ID: 35172090 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease. Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007 [TBL] [Abstract][Full Text] [Related]
48. Mammographic masses characterization based on localized texture and dataset fractal analysis using linear, neural and support vector machine classifiers. Mavroforakis ME; Georgiou HV; Dimitropoulos N; Cavouras D; Theodoridis S Artif Intell Med; 2006 Jun; 37(2):145-62. PubMed ID: 16716579 [TBL] [Abstract][Full Text] [Related]
49. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains. Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054 [TBL] [Abstract][Full Text] [Related]
50. Combining Diffusion Tensor Imaging and Susceptibility Weighted Imaging on the Substantia Nigra of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP)-induced Rhesus Monkey Model of Parkinson's Disease. Zhang Q; Li L; Miao B; Niu H West Indian Med J; 2015 Dec; 64(5):480-486. PubMed ID: 27400227 [TBL] [Abstract][Full Text] [Related]
51. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487 [TBL] [Abstract][Full Text] [Related]
52. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes. George G; Valiya Parambath S; Lokappa SB; Varkey J Gene; 2019 May; 697():67-77. PubMed ID: 30776463 [TBL] [Abstract][Full Text] [Related]
53. Artificial Neural Network-Based Prediction of Outcome in Parkinson's Disease Patients Using DaTscan SPECT Imaging Features. Tang J; Yang B; Adams MP; Shenkov NN; Klyuzhin IS; Fotouhi S; Davoodi-Bojd E; Lu L; Soltanian-Zadeh H; Sossi V; Rahmim A Mol Imaging Biol; 2019 Dec; 21(6):1165-1173. PubMed ID: 30847821 [TBL] [Abstract][Full Text] [Related]
54. Characterization of Adrenal Lesions on Unenhanced MRI Using Texture Analysis: A Machine-Learning Approach. Romeo V; Maurea S; Cuocolo R; Petretta M; Mainenti PP; Verde F; Coppola M; Dell'Aversana S; Brunetti A J Magn Reson Imaging; 2018 Jul; 48(1):198-204. PubMed ID: 29341325 [TBL] [Abstract][Full Text] [Related]
55. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Vallières M; Freeman CR; Skamene SR; El Naqa I Phys Med Biol; 2015 Jul; 60(14):5471-96. PubMed ID: 26119045 [TBL] [Abstract][Full Text] [Related]
56. [Morphochemical changes in the substantia nigra cellular structures in Parkinson's disease]. Salkov VN; Khudoerkov RM; Voronkov DN; Sobolev VB; Kutukova KA Arkh Patol; 2017; 79(5):3-9. PubMed ID: 29027522 [TBL] [Abstract][Full Text] [Related]
57. Optimized machine learning methods for prediction of cognitive outcome in Parkinson's disease. Salmanpour MR; Shamsaei M; Saberi A; Setayeshi S; Klyuzhin IS; Sossi V; Rahmim A Comput Biol Med; 2019 Aug; 111():103347. PubMed ID: 31284154 [TBL] [Abstract][Full Text] [Related]
58. Parkinson's Disease Classification of mPower Walking Activity Participants. Pittman B; Ghomi RH; Si D Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():4253-4256. PubMed ID: 30441293 [TBL] [Abstract][Full Text] [Related]
59. Integration of morphological preprocessing and fractal based feature extraction with recursive feature elimination for skin lesion types classification. Chatterjee S; Dey D; Munshi S Comput Methods Programs Biomed; 2019 Sep; 178():201-218. PubMed ID: 31416550 [TBL] [Abstract][Full Text] [Related]
60. Deep brain stimulation induced normalization of the human functional connectome in Parkinson's disease. Horn A; Wenzel G; Irmen F; Huebl J; Li N; Neumann WJ; Krause P; Bohner G; Scheel M; Kühn AA Brain; 2019 Oct; 142(10):3129-3143. PubMed ID: 31412106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]